DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Reddy Holding Gmbh
02 8Celltrion Healthcare Hungary Kft
03 2Celltrion Healthcare Hungary Kft.
04 2Iqone Healthcare Switzerland Sa
05 2Pfizer Ag
06 4Pfizer Europe Ma Eeig
07 3ROCHE REGISTRATION LTD
08 6Roche Pharma (Switzerland) Ag
09 7Roche Registration Gmbh
10 8Sandoz Gmbh
11 2Sandoz Pharmaceuticals Ag
01 46Rituximab
01 10Concentrate For Infusion Solution
02 26Concentrate For Solution For Infusion
03 2Injectable Solution
04 1Rituximab 100Mg 10Ml 2 Units Parenteral Use
05 1Rituximab 140011,7Mg Ml 1 Units Parenteral Use
06 1Rituximab 500Mg 50Ml 1 Units Parenteral Use
07 2Solution For Injection
08 3Subcutaneous Injectable Solution
01 3Italy
02 11Spain
03 20Sweden
04 12Switzerland
01 2Blitzima
02 2Ituxredi
03 2MabThera
04 2MabThera subcutaneous
05 10Mabthera
06 2Ristova
07 2Ritemvia
08 2Rituzena
09 6Rixathon
10 4Riximyo
11 6Ruxience
12 6Truxima
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Ituxredi
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 100mg
Packaging :
Approval Date : 19/09/2024
Application Number : 20230426000122
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Ituxredi
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 19/09/2024
Application Number : 20230426000139
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Blitzima
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 100mg
Packaging :
Approval Date : 30/11/2017
Application Number : 20171219000038
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Blitzima
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 13/07/2017
Application Number : 20170307000011
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Mabthera
Dosage Form : Rituximab 100Mg 10Ml 2 Units Parenteral Use
Dosage Strength : 2 VIALS EV 100 mg 10 ml 10 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Mabthera
Dosage Form : Rituximab 500Mg 50Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 500 mg 50 ml 10 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Mabthera
Dosage Form : Rituximab 140011,7Mg Ml 1 Units Parenteral Use
Dosage Strength : 1 vial SC 1,400 mg/11.7 ml 15 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Mabthera
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 100mg
Packaging :
Approval Date : 02/06/1998
Application Number : 19980602000012
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Mabthera
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 02/06/1998
Application Number : 19980602000029
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Mabthera
Dosage Form : Injectable Solution
Dosage Strength : 1400mg
Packaging :
Approval Date : 21/03/2014
Application Number : 20130208000060
Regulatory Info : Approved
Registration Country : Sweden
